To determine whether there was an association between GAS7 expression levels and clinical parameters in breast cancer patients, the mRNA samples from 38 pairs of primary and lymph node metastatic tumors, as well as commercial breast cancer tissue arrays, were analyzed by RT-qPCR and immunohistochemistry (IHC) assays, respectively. The gene discussed is GAS7; the disease is breast carcinoma.